Connect your AI

LONA LONA Change in Other Liabilities

Change in Other Liabilities at other companies

Olema Pharmaceuticals, Inc.OLMA

$1.3M+112%

Arcus BiosciencesRCUS

-$16M+5.9%

Other financials

Income statement

Operating income-$17.2M-80.5%

Net income-$32.9M-260%

EPS (diluted)-$1.73+26.1%

Balance sheet

Cash & equivalents$32.8M+24.3%

Total debt$691.0K-38.2%

Total equity$49.3M+32.1%

Total assets$71.6M+64.5%

Cash flow

Operating cash flow-$20.9M-42.5%

CapEx$28.0K-15.2%

Free cash flow-$26.0M+1.1%

Valuation

Market cap$86.33M+223%

Enterprise value$54.18M—

Returns & leverage

Return on equity-298.8%-726pp

Debt / equity0×0.0×

Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LONA's change in other liabilities?: LONA (LONA) reported change in other liabilities of -$183K in Q1 2026.
How has LONA's change in other liabilities changed year-over-year?: LONA's change in other liabilities decreased by 1140.7% year-over-year, from -$14.75K to -$183K.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.